Eterna Therapeutics Inc.

Informe acción NasdaqCM:ERNA

Capitalización de mercado: US$5.6m

Eterna Therapeutics Dirección

Dirección controles de criterios 0/4

We currently do not have sufficient information about the CEO.

Información clave

Sanjeev Luther

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directiva1.5yrs

Actualizaciones recientes de la dirección

Recent updates

Brooklyn Immunotherapeutics announces name change to Eterna Therapeutics

Oct 11

Brooklyn ImmunoTherapeutics releases head and neck cancer phase 2 trial results

Jul 26

CEO

Sanjeev Luther (62 yo)

less than a year

Permanencia

Mr. Sanjeev Luther serves as President, Chief Executive Officer and as a Director at Eterna Therapeutics Inc. since January 01, 2024. He served as the Chief Executive Officer, President & Director at Corne...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Sandra Gurrola
Principal Financial & Accounting Officer and Senior VP of Finance2.5yrsUS$305.88k0.022%
$ 1.2k
Sanjeev Luther
CEO, President & Directorless than a yearsin datossin datos
Robert Pierce
Chief Scientific Officerless than a yearsin datossin datos
Dorothy Clarke
General Counsel & Directorless than a yearsin datos0%
$ 0

0.8yrs

Permanencia media

59.5yo

Promedio de edad

Equipo directivo experimentado: ERNA's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Sanjeev Luther
CEO, President & Directorless than a yearsin datossin datos
Dorothy Clarke
General Counsel & Director1.3yrssin datos0%
$ 0
Sol Barer
Advisor to the Boardno datasin datossin datos
William Wexler
Independent Director2.4yrsUS$112.29k0%
$ 0
Michael Andreeff
Member of Scientific Advisory Board3.5yrssin datossin datos
James Bristol
Independent Chairman of the Board1.1yrssin datossin datos
Jeffrey Karp
Member of Scientific Advisory Board1.7yrssin datossin datos
Christopher Rohde
Member of Scientific Advisory Board3.5yrssin datossin datos
Peter Cicala
Independent Directorless than a yearsin datossin datos

1.5yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: ERNA's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.